useyourbrainforex
Pfizer launches $1.5B cost-cutting program amid stock volatility and declining COVID-19 sales
U.S. pharmaceutical giant Pfizer announced on Wednesday the initiation of a new multi-year program aimed at reducing its expenses by...
top of page
bottom of page